Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 50 of 71 entries
View as:

MYPHISMO: MYB and PD-1 Immunotherapies Against Multiple Oncologies Trial

Phase: N/A Priority: Normal
NCT ID: NCT03287427 Org: User:
Start: 08/22/18 End: 12/14/22 Due: 12/14/23

A Study of Peripheral Blood Progenitor Cells Mobilisation (PBPC) With VTP195183 Plus Granulocyte-Colony Stimulating Factor (G-CSF) Compared to Mobilisation With G-CSF Alone

Phase: N/A Priority: Normal
NCT ID: NCT00234169 Org: User:
Start: 10/31/05 End: 01/31/08 Due: 01/31/09

Stereotactic Radiotherapy and Anti-PD1 Antibody (Pembrolizumab) for Oligometastatic Renal Tumours

Phase: N/A Priority: Normal
NCT ID: NCT02855203 Org: User:
Start: 10/20/16 End: 05/22/20 Due: 05/22/21

Tirapazamine, Cisplatin, and Radiation Therapy in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00098995 Org: User:
Start: 12/31/04 End: 01/31/10 Due: 01/31/11

Safety and Oversight of the Individually Tailored Treatment Approach: A Novel Pilot Study

Phase: N/A Priority: Normal
NCT ID: NCT04801966 Org: User:
Start: 09/23/21 End: 12/30/22 Due: 12/30/23

Study of Lenalidomide, Venetoclax and Obinutuzumab in Patients With Treatment-Naïve Follicular Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT03980171 Org: User:
Start: 08/19/19 End: 11/30/26 Due: 11/30/27

ATRA Plus G-CSF for Mobilization of Hematopoietic Stem and Progenitor Cells

Phase: N/A Priority: Normal
NCT ID: NCT00400556 Org: User:
Start: 03/31/05 End: 05/31/05 Due: 05/31/06

Volatile Anaesthesia and Perioperative Outcomes Related to Cancer Feasibility Study

Phase: N/A Priority: Normal
NCT ID: NCT04074460 Org: User:
Start: 08/27/17 End: 06/30/20 Due: 06/30/21

A Single Arm Pilot Study of Azacitidine in Myelodysplastic Syndromes (MDS) / Acute Myeloid Leukaemia (AML), With Eltrombopag Support for Thrombocytopenia

Phase: N/A Priority: Normal
NCT ID: NCT01488565 Org: User:
Start: 12/31/10 End: 05/31/15 Due: 05/31/16

A Pilot Study of Focal Ablative STereotactic RAdiosurgery for Cancers of the Kidney or Isolated Adrenal Metastases

Phase: N/A Priority: Normal
NCT ID: NCT01676428 Org: User:
Start: 05/31/12 End: 11/30/15 Due: 11/30/16

A Pilot Study of Oral Vorinostat Plus Oral Eltrombopag Support in Patients With Lymphoma (VEIL)

Phase: N/A Priority: Normal
NCT ID: NCT01500538 Org: User:
Start: 10/31/12 End: 05/31/14 Due: 05/31/15

177Lu-PSMA-617 Therapy and Olaparib in Patients With Metastatic Castration Resistant Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03874884 Org: User:
Start: 07/09/19 End: 06/30/26 Due: 06/30/27

MRD-Directed Consolidation With Epcor-only or Epcor-R2 Post Anti-CD19 CAR TCell Therapy for Large B-Cell Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT06414148 Org: User:
Start: 05/14/24 End: 05/31/28 Due: 05/31/29

Sequencing of Stereotactic Ablative Body Radiotherapy in Combination With PD-1 Blockade Using Pembrolizumab in Metastatic Non-Small Cell Lung Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT03307759 Org: User:
Start: 12/07/17 End: 01/31/22 Due: 01/31/23

Pidnarulex and Talazoparib in Patients With Metastatic Castration Resistant Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05425862 Org: User:
Start: 10/21/22 End: 12/30/25 Due: 12/30/26

Deep sequencIng in Cutaneous Squamous CEll caRciNomas

Phase: N/A Priority: Normal
NCT ID: NCT05878288 Org: User:
Start: 05/26/23 End: 05/31/29 Due: 05/31/30

High Intensity Functional Image Guided Vmat Lung Evasion

Phase: N/A Priority: Normal
NCT ID: NCT03569072 Org: User:
Start: 07/01/18 End: 01/27/21 Due: 01/27/22

Combination of Radium-223 and Lutetium-177 PSMA-I&T in Men with Metastatic Castration-Resistant Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05383079 Org: User:
Start: 09/13/22 End: 12/01/26 Due: 12/01/27

Clinical Trial to Assess The Efficacy and Safety of the Combination of Tisagenlecleucel And Ibrutinib in Mantle Cell Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT04234061 Org: User:
Start: 04/07/20 End: 09/01/30 Due: 09/01/31

Stereotactic Radiation and Immunotherapy in Patients With Advanced Triple Negative Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03464942 Org: User:
Start: 08/01/18 End: 06/22/23 Due: 06/22/24

CAR-T Cell Therapy in RelApsed/Refractory Myeloma With ExtrameduLlary Disease - an in Vivo Imaging and Molecular Monitoring Study

Phase: N/A Priority: Normal
NCT ID: NCT05666700 Org: User:
Start: 12/08/23 End: 01/31/27 Due: 01/31/28

A Study of APR-246 in Oesophageal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02999893 Org: User:
Start: 04/11/17 End: 02/07/21 Due: 02/07/22

The Evaluating Multidisciplinary Bone Marrow Failure Care in Bone Marrow Failure and Related Disorders.

Phase: N/A Priority: Normal
NCT ID: NCT04819607 Org: User:
Start: 06/09/21 End: 04/30/24 Due: 04/30/25

A Single Arm Trial of Oxaliplatin and 5FU With Concurrent Radiation in Patients With Metastatic Rectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00422864 Org: User:
Start: 10/31/06 End: 01/31/11 Due: 01/31/12

PET/CT and Bacterial/Fungal PCR in High Risk Febrile Neutropenia

Phase: N/A Priority: Normal
NCT ID: NCT03429387 Org: User:
Start: 01/08/18 End: 01/23/21 Due: 01/23/22